Japanese Regulatory Strategy & PMDA consultation Regulatory and Clinical Development strategy Evaluation of possible Regulatory pathways in Japan such as Sakigake, early conditional approval and others CMC requirements and gap analysis Forecast and recommendations Alignment of Japan regulatory strategy with global strategy Evaluation of suitability of non-clinical, clinical and CMC package for development and registration in Japan Registration strategy Evaluation of different entry options to Japan market Scientific advice with PMDA including preparation of brief book We Are Your Partner for Success in Japan Get in touch